Clinical and serological prognostic markers in primary biliary cholangitis

키워드

참고문헌 (11)

1. Atsushi Tanaka, "Current understanding of primary biliary cholangitis", Clinical and Molecular Hepatology, 27(1), pp.1~21 (2021), 대한간학회[DOI]
2. Quarneti C, "Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis", Liver Int, 35, pp.636~641 (2015)
3. Carbone M, "Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid", Gastroenterology, 144, pp.560~569.e7 (2013)
4. Huang C, "Early prognostic utility of gp210 antibody-positive rate in primary biliary cholangitis:a meta-analysis", Dis Markers, 2019, pp.9121207~ (2019)
5. Granito A, "Antinuclear antibodies as ancillary markers in primary biliary cirrhosis", Expert Rev Mol Diagn, 12, pp.65~74 (2012)
6. Muratori P, "Multiple nuclear dots and rim-like", membranous IgG isotypes in primary biliary cirrhosis, 2009, pp.42, 224~227
7. Granito A, "PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis", Am J Gastroenterol, 105, pp.125~131 (2010)
8. Muratori P, "Autoimmune liver disease 2007", Mol Aspects Med, 29, pp.96~102 (2008)
9. Granito A, "Surrogate markers for antimitochondrial antibody-negative primary biliary cholangitis", Am J Gastroenterol, 116, pp.215~217 (2021)
10. Granito A, "Antibodies to SS-A", Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis, 2007, pp.26, 831~838
11. Granito A, "Antinuclear antibodies giving the ‘multiple nuclear dots’ or the ‘rim-like", membranous’ patterns: diagnostic accuracy for primary biliary cirrhosis, 2006, pp.24, 1575~1583

관련 논문AI추천